Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome
Condition: Steroid-Sensitive Nephrotic Syndrome Intervention: Drug: Rituximab Sponsors: Children's Hospital of Fudan University; Children's Hospital of Nanjing Medical University; The Children's Hospital of Zhejiang University School of Medicine; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Wuhan Union Hospital, China; Anhui Provinc ial Children's Hospital; Shanghai Children's Hospital; Children's Hospital Affiliated to Zhengzhou University/Henan Children's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2021 Category: Research Source Type: clinical trials
Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic Syndrome
Condition: Steroid-Sensitive Nephrotic Syndrome Intervention: Drug: Prednisolone Sponsor: Shaheed Zulfiqar Ali Bhutto Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2021 Category: Research Source Type: clinical trials
